Copyright
©The Author(s) 2025.
World J Clin Oncol. May 24, 2025; 16(5): 106292
Published online May 24, 2025. doi: 10.5306/wjco.v16.i5.106292
Published online May 24, 2025. doi: 10.5306/wjco.v16.i5.106292
Table 1 Primary sellar atypical teratoid/rhabdoid tumor cases confirmed by molecular studies
Ref. | Age | Sex | Molecular diagnosis | Headache duration | Visual symptoms duration | Pituitary hormones | Imaging features | Surgery | Chemotherapy | Radiation | Outcome |
Zamudio-Coronado et al[23], 2023 | 60 | F | Loss of INI1 SMARCB1 mutations | No headache | 2 months | Normal | 1.3 cm with cavernous sinus invasion | Total resection, rapid recurrence | Yes | Yes | Did not specify |
Aldhafeeri et al[24], 2023 | 32 | M | Loss of INI1 | 4 days | ND | Hypopituitarism | Large sellar mass with suprasellar distension | Debulking | No | No | Died 3 months after presentation |
Yu[14], 2023 | 45 | F | Loss of INI1 (Met) | 3 weeks | 1 week | Hypopituitarism | 1.9 cm × 2.2 cm × 1.8 cm | Debulking | No | No | Alive 1 month after presentation |
Yu[14], 2023 | 32 | F | Loss of INI1 (Met) | 1 month | 1 week | Normal | 2.1 cm | Debulking | No | Yes | Died 4 months after presentation |
Baiano et al[25], 2022 | 32 | F | Loss of INI1 (Met) | 2 months | 10 days | Elevated prolactin | Large | Debulking | Yes | No | Died 2 months after presentation |
Baiano et al[25], 2022 | 42 | F | Loss of INI1 (Met) | Intense | ND | ND | Large | Debulking | Yes | No | Died 2 months after presentation |
Baiano et al[25], 2022 | 41 | F | Loss of INI1 (Met) | ND | ND | Hypopituitarism | Large | Debulking | No | No | Died 1 month after presentation |
Baiano et al[25], 2022 | 50 | F | Loss of INI1 | Intense | ND | Hypopituitarism | Large | Debulking | Yes | No | Alive 18 months after presentation |
Major et al[11], 2022 | 70 | F | Loss of INI1 | 3 months | 4 months | ND | 1.8 cm × 2.2 cm × 1.7 cm | Debulking | Yes | Yes | Died 8.5 months after presentation |
Duan et al[26], 2022 | 47 | F | Loss of INI1 (Met) | ND | ND | 6/7 have hypopituitarism | Large | Debulking | No | No | Died 6 months after presentation |
Duan et al[26], 2022 | 52 | F | Loss of INI1 (Met) | ND | ND | 6/7 have hypopituitarism | Large | Debulking | No | No | Died 2.5 months after presentation |
Duan et al[26], 2022 | 47 | M | Loss of INI1 (Met) | ND | ND | 6/7 have hypopituitarism | Large | Debulking | No | Yes | Died 1 month after presentation |
Duan et al[26], 2022 | 46 | F | Loss of INI1 (Met) | ND | ND | 6/7 have hypopituitarism | Large | Debulking | No | No | Died 6 months after presentation |
Duan et al[26], 2022 | 45 | F | Loss of INI1 (Met) | ND | ND | 6/7 have hypopituitarism | Large | Debulking | No | No | Died 1 month after presentation |
Duan et al[26], 2022 | 73 | F | Loss of INI1 (Met) | ND | ND | 6/7 have hypopituitarism | Large | Debulking | No | No | Died 3 months after presentation |
Duan et al[26], 2022 | 41 | F | Loss of INI1 (Met) | ND | ND | 6/7 have hypopituitarism | Large | Debulking | No | No | Alive 11 months after presentation |
Fukuda et al[27], 2021 | 45 | F | Loss of INI1 | ND | A few weeks | Hypopituitarism | Large | Debulking | Yes | Yes | Died 5 months after presentation |
Liu et al[28], 2020 | 43 | F | Loss of INI1 | 1 month | 1 month | Normal | 4.5 cm | Debulking | No | Yes | Died 4 months after presentation |
Liu et al[28], 2020 | 52 | F | Loss of INI1 | 2 weeks | ND | Hypopituitarism | 2.8 cm | Debulking | No | No | Died 2 months after presentation |
Liu et al[28], 2020 | 50 | F | Loss of INI1 | 2 months | 2 months | Hypopituitarism | 2.7 cm | Debulking | No | No | Died 1 month after presentation |
Liu et al[28], 2020 | 29 | F | Loss of INI1 | 4 months | ND | Hypopituitarism | 1.9 cm | Debulking | Yes | Yes | Died 8 months after presentation |
Liu et al[28], 2020 | 80 | F | Loss of INI1 | 2 weeks | 2 weeks | Hypopituitarism | 2.2 cm | Debulking | No | No | Died 1 month after presentation |
Bokhari et al[29], 2020 | 40 | F | Loss of INI1 | Severe | ND | ND | 2.9 cm × 1.7 cm × 2.3 cm | Debulking | None | None | ND |
Madhavan et al[30], 2020 | 58 | F | Loss of INI1 | ND | ND | Hypopituitarism | 2.1 cm sellar mass with 3.1 cm suprasellar extension | Debulking | No | No | ND |
Siddiqui et al[31], 2019 | 55 | F | Loss of INI1 | 1 week | 1 week | ND | 3.5 cm × 1.7 cm | Debulking | No | No | Died 1 .5 months after presentation |
Asmaro et al[32], 2019 | 62 | F | Loss of INI1 | Several months | ND | Hypopituitarism | Large | Debulking | No | No | Died 2 months after presentation |
Lawler and Robertson[33], 2019 | 27 | F | Loss of INI1 | ND | ND | ND | Large | Debulking | ND | ND | ND |
Su and Su[34], 2018 | 37 | F | Loss of INI1 | ND | 2 months | ND | 2.57 cm × 1.96 cm × 3.63 cm | Debulking | No | No | Died 3 months after presentation |
Nishikawa et al[35], 2018 | 42 | F | Loss of INI1 | Rapid | Rapid | ND | 1.9 cm × 2.0 cm | Debulking | Yes | Yes | Died 11 months after presentation |
Barresi et al[36], 2018 | 59 | F | Loss of INI1 | Days | Days | 2.3 cm × 1.2 cm | Debulking | No | No | Died 2 months after presentation | |
Paolini et al[37], 2018 | 31 | F | Loss of INI1 | ND | ND | ND | ND | Debulking | No | No | Died 2 months after presentation |
Paolini et al[37], 2018 | 36 | F | Loss of INI1 | ND | ND | ND | ND | Debulking | Yes | Yes | Alive 22 months after presentation |
Paolini et al[37], 2018 | 46 | F | Loss of INI1 | ND | ND | ND | ND | Debulking | No | No | Died after 2nd resection |
Paolini et al[37], 2018 | 47 | F | Loss of INI1 | ND | ND | ND | ND | Debulking | Yes | Yes | Alive 62 months after presentation |
Paolini et al[37], 2018 | 65 | f | Loss of INI1 | ND | ND | ND | ND | Debulking | Yes | Yes | Died 23 months after presentation |
Johann et al[38], 2018 | 20 | F | Loss of INI1 (met) | ND | ND | ND | ND | Debulking | Yes | No | Died 10 years after presentation |
Johann et al[38], 2018 | 48 | F | Loss of INI1 (Met) | ND | ND | ND | ND | Debulking | No | No | Alive 4 months after presentation |
Huq et al[39], 2018 | 62 | F | Loss of INI1 | 2 months | Finally | Hypopituitarism | Large | Debulking | No | No | Died 2 months after presentation |
Pratt et al[40], 2017 | 47 | F | Loss of INI1 | Severe | ND | ND | 2.6 cm × 3.9 cm × 3.2 cm | Debulking | No | Yes | ND |
Nakata et al[41], 2017 | 31 | F | Loss of INI1 | ND | ND | ND | ND | Debulking | Yes | Yes | Died 28 months after presentation |
Nakata et al[41], 2017 | 56 | F | Loss of INI1 | ND | ND | ND | ND | Debulking | No | Yes | Died 23 months after presentation |
Nakata et al[41], 2017 | 44 | F | Loss of INI1 | ND | ND | ND | ND | Debulking | Yes | Yes | Died 17 months after presentation |
Nakata et al[41], 2017 | 26 | F | Loss of INI1 | ND | ND | ND | ND | Debulking | Yes | Yes | Died 33 months after presentation |
Nakata et al[41], 2017 | 21 | F | Loss of INI1 | ND | ND | ND | ND | Debulking | Yes | Yes | Died 35 months after presentation |
Nakata et al[41], 2017 | 69 | F | Loss of INI1 | ND | ND | ND | ND | Debulking | Yes | Yes | Alive 37 months after presentation |
Almalki et al[42], 2017 | 36 | F | Loss of INI1 | 3 months | 1 month | Hypopituitarism | Large | Debulking | Yes | Yes | Alive 3 years after presentation |
Elsayad et al[43], 2016 | 66 | M | Loss of INI1 | ND | ND | ND | 2.2 cm × 1.6 cm × 1.4 cm | Debulking | No | Yes | Alive 4 years after presentation |
Larran-Escandon et al[44], 2016 | 43 | F | Loss of INI1 | 3 months | 2 weeks | Hypopituitarism | 2.0 cm × 2.3 cm | Debulking | No | No | Died 1 month after presentation |
Nobusawa et al[45], 2016 | 69 | F | Loss of INI1 (Met) | ND | Nost specified. Progressed over a few days | ND | 2.8 cm × 1.6 cm | Debulking | Yes | Yes | Alive 2 years after presentation |
Lev et al[13], 2015 | 36 | F | Loss of INI1 | 1 months | 6 days | Hypopituitarism | 3.3 cm × 3.2 cm × 2.3 cm | Debulking | Yes | Yes | Died 2.5 years after presentation |
Biswas et al[46], 2015 | 48 | F | Loss of INI1 | ND | 2 weeks | ND | ND | Debulking | Yes | Yes | Died 2 months after presentation |
Regan et al[47], 2015 | 45 | F | Loss of INI1 | 9 days | 9 days | ND | Large | Debulking | No | Yes | Died 6 months after presentation |
Park et al[48], 2014 | 42 | F | Loss of INI1 | ND | Progressive | ND | Large | Debulking | Yes | Yes | Alive 2 years after presentation |
Shitara and Akiyama[49], 2014 | 44 | F | Loss of INI1 | ND | 2 months | ND | Large | Debulking | Yes | Yes | Alive 17 months after presentation |
Moretti et al[50], 2013 | 60 | F | Loss of INI1 | ND | ND | ND | Large | Debulking | Yes | Yes | Alive 30 months after presentation |
Chou et al[51], 2013 | 43 | F | Loss of INI1 | 10 days | 10 days | ND | 2 cm | Debulking | No | Yes | Alive at 2 weeks |
Schneiderhan et al[52], 2011 | 61 | F | Loss of INI1 (Met) | ND | ND | ND | 2 cm | Debulking | No | No | Died 3 months after presentation |
Schneiderhan et al[52], 2011 | 57 | F | Loss of INI1 | ND | ND | ND | 2 cm | Debulking | Yes | Yes | Alive 6 months after presentation |
Las Heras and Pritzker[53], 2010 | 46 | F | Loss of INI1 | ND | ND | ND | ND | Debulking | ND | ND | ND |
Arita et al[54], 2008 | 56 | F | Loss of INI1 (Met) | 2 months | 2 months | ND | 2.5 cm | Debulking | No | Yes | Died 23 months after presentation |
Raisanen et al[55], 2005 | 31 | F | Loss of INI1 | ND | ND | ND | 1.6 cm | Debulking | No | Yes | Died 9 months after presentation |
Raisanen et al[55], 2005 | 20 | F | Loss of INI1 | ND | ND | ND | 2.0 cm | Debulking | Yes | Yes | Alive 28 months after presentation |
Table 2 Sellar compression symptoms, pituitary hormone status, and pituitary magnetic resonance imaging findings of major sellar lesions
Acuity of sellar compression symptoms | Pituitary hormone status | Pituitary MRI | Other clinical clues | |
Apoplexy | Hyperacute (hours) | Hypopituitarism | With hemorrhage | Known history of pituitary adenoma |
Sellar AT/RT | Acute (days to weeks) | Hypopituitarism | Invasive mass | Predominantly in females |
Pituitary adenoma | Chronic (months) | Pituitary hormone excess or deficiency | Noninvasive or invasive | History of genetic syndromes |
Sellar lymphoma | Chronic (months) | Hypopituitarism | Invasive mass | Unclear |
Sellar metastasis | Chronic (months) | Hypopituitarism | Invasive mass | Known malignancies |
Hypophysitis | Chronic (months) | Hypopituitarism | Thickened stalk | Postpartum females |
- Citation: Yu R. Importance of symptoms acuity for clinical diagnosis of primary sellar atypical teratoid/rhabdoid tumor. World J Clin Oncol 2025; 16(5): 106292
- URL: https://www.wjgnet.com/2218-4333/full/v16/i5/106292.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i5.106292